Loading...

DarioHealth Corp.

DRIO•NASDAQ
Healthcare
Medical - Diagnostics & Research
$7.41
$0.21(2.92%)
U.S. Market opens in 23h 4m

DarioHealth Corp. (DRIO) Stock Overview

Explore DarioHealth Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap54.1M
P/E Ratio5.88
EPS (TTM)$-10.12
ROE0.88%
Fundamental Analysis

AI Price Forecasts

1 Month$8.97
3 Months$15.59
1 Year Target$19.56

DRIO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of DarioHealth Corp. (DRIO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.89, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $19.56.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 5.88 and a market capitalization of 54.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.92%
5-Day Change
1.93%
1-Month Change
-4.51%
3-Month Change
-36.34%
6-Month Change
-54.23%
Year-to-Date (YTD) Change
-34.89%
1-Year Change
-54.82%
3-Year Change
-89.26%
5-Year Change
-98.23%
All-Time (Max) Change
-99.49%

Contact Information

https://www.mydario.com
833 914 3796
18 West 18th Street, New York City, NY, 10011

Company Facts

196 Employees
IPO DateMar 14, 2016
CountryUS
Actively Trading

Frequently Asked Questions